[18F]PI-2620
IIBSP-DOW-2022-150
Phase 2 small_molecule active
Quick answer
[18F]PI-2620 for Down Syndrome., Alzheimer´s Disease. is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Down Syndrome., Alzheimer´s Disease.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active